Tecentriq Approved as First Immunotherapy for BC

Options
Moderators
Moderators Member Posts: 25,912

Tecentriq Approved as First Immunotherapy for Breast Cancer
March 8, 2019

On March 8, 2019, the FDA approved Tecentriq in combination with the chemotherapy medicine Abraxane as a first treatment for unresectable locally advanced or metastatic triple-negative, PD-L1-positive breast cancer. Read more...

Categories